Quanta Services (PWR) delivered earnings and revenue surprises of +28.88% and +12.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Starbucks Delivers Blowout Quarter, Stock Pops on Strong Sales Growth
Pagaya Technologies Ltd. (PGY) delivered earnings and revenue surprises of +50.70% and +8.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Blue Owl Capital (OWL) delivered earnings and revenue surprises of 0.00% and +1.12%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Altria (MO) delivered earnings and revenue surprises of -1.33% and -0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Huntington Ingalls (HII) delivered earnings and revenue surprises of +38.68% and +8.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
CCC Intelligent Solutions (CCC) delivered earnings and revenue surprises of 0.00% and +0.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Bristol Myers (BMY) delivered earnings and revenue surprises of +28.30% and +11.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AMC Global Media (AMCX) delivered earnings and revenue surprises of -2,700.00% and -2.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Allegro MicroSystems (ALGM) delivered earnings and revenue surprises of +9.52% and +2.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AEP (AEP) delivered earnings and revenue surprises of -8.73% and +3.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell heads into Q2 earnings with tighter petrochemical supply, stronger pricing and a Bayport restart expected to support margins and profitability.
Moby summary of Hexcel Corporation's Q2 2026 earnings call
Moby summary of Endeavour Silver Corp.'s Q2 2026 earnings call
Moby summary of Teladoc Health, Inc.'s Q2 2026 earnings call
Moby summary of Magnachip Semiconductor Corporation's Q2 2026 earnings call
Moby summary of Green Brick Partners, Inc.'s Q2 2026 earnings call
Moby summary of Generac Holdings Inc.'s Q2 2026 earnings call
Moby summary of Climb Global Solutions, Inc.'s Q2 2026 earnings call
Moby summary of Kinross Gold Corporation's Q2 2026 earnings call
Moby summary of EPR Properties's Q2 2026 earnings call
Moby summary of Agnico Eagle Mines Limited's Q2 2026 earnings call
Event contracts brought in $156 million while crypto revenue fell 38% to $100 million
Quanta Services, the nation's largest electrical infrastructure construction company, blew away second-quarter earnings forecasts and massively raised its full-year outlook amid the artificial intelligence buildout boom. Quanta said its improved visibility, record backlog and four recently completed acquisitions played into the big increase in its 2026 outlook. "We believe these results and our long-term track record are a clear differentiator of Quanta's ability to compound profitable growth as our customers accelerate investment in the electric grid, power generation and mission-critical infrastructure that underpin the economy," CEO Duke Austin said in the earnings statement.
Chip designer Allegro MicroSystems (NASDAQ:ALGM) announced better-than-expected revenue in Q2 CY2026, with sales up 27.5% year on year to $259.2 million. Guidance for next quarter’s revenue was optimistic at $270 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $0.23 per share was 8.8% above analysts’ consensus estimates.
Shares of capital market company MSCI and credit rating agency Equifax both posted double-digit declines in response to lackluster earnings.
Strong sales of blood thinner Eliquis and newer drugs Camzyos and Reblozyl pushed second-quarter revenue to $12.97 billion, above analyst estimates
PSX heads into Q2 earnings with stronger estimates, softer crude costs and refinery strength, though its premium valuation raises the stakes.
Carvana stock declines with Wall Street unwilling to ‘reward’ the used-car retailer’s full-year earnings guidance.